NASDAQ: SBRA · Healthcare Facility REITs

Sabra Health Care REIT (SBRA) fair value: undervalued or overvalued?

As of 14 Nov 2026, Faircurve's model values Sabra Health Care REIT (SBRA) at $20.72 a share. The stock last closed at $20.35, which puts the model's fair value 1.8% above the price. On the model's bands that reads as Fairly valued.

Revalued . Price is the close of 16 Nov 2026. Sabra Health Care REIT, Inc.

The report adds the live price, the price chart and the next earnings date. No account needed.

Model fair value$20.72blend of three valuation methods
Last close$20.35NASDAQ: SBRA
Gap to fair value+1.8%fair value against price
Model verdictFairly valuedevidence grade: High

This week, in three parts

What happenedThe run of 14 Nov 2026 moved the fair value from $17.16 to $20.72 (+20.7%). The model does not yet explain moves on this valuation method.

What the model makes of itThe price of $20.35 is 1.8% below it: Fairly valued, on a high evidence grade.

What's nextNext report on 11 Feb 2027. The next weekly run is on Saturday 21 Nov 2026.

What price range does the model give SBRA?

The calibrated range for SBRA over 63 trading days is $16.57 to $24.62. There is no live options data for this stock, so the range is built from the fair value and calibrated weekly against realised prices (n = 13,250 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon.

The model's own range is $19.21 to $22.35.

$16.77$25.68
The shape of the range around the fair value, from 2,000 simulations of the dividend model. Solid line: the fair value, $20.72. Dashed line: the last close, $20.35.

Faircurve Insights · 14 Nov 2026

Sabra Health Care REIT, Inc. (SBRA) engages in acquiring, financing and owning real estate property. It is headquartered in Tustin, CA.

Faircurve's model puts the fair value at $20.72 a share, run on 14 Nov 2026. The previous run, on 7 Nov 2026, gave $17.16, so the fair value moved +20.7%. The model does not yet explain moves on this valuation method. The calibrated range over 63 trading days is $16.57 to $24.62, built from the fair value, since there is no live options data for the stock. It is calibrated weekly against realised prices, using 13,250 past valuations. Ranges built this way held the price 60% of the time at this horizon. The evidence grade is High. For REITs it looks at the dividend record: at least three years of paid dividends with no cut. It does not say whether the fair value is right.

No quality score for the business is available for this note, so its standing against peers on quality is not reported. The model compares Sabra with Healthcare Realty Trust Incorporated (HR), CareTrust REIT, Inc. (CTRE), LTC Properties, Inc. (LTC), Healthpeak Properties, Inc. (DOC), Omega Healthcare Investors, Inc. (OHI) and Ventas, Inc. (VTR), each with a fair value of its own on the site. American Healthcare REIT, Inc. (AHR) and Medical Properties Trust, Inc. (MPT) have no verdict on this date.

Written from the figures on this page for the 14 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.

The Global Pulse

Faircurve's note after each US session, in your inbox. No account needed.

When does SBRA report earnings, and how has the stock reacted?

Sabra Health Care REIT's next earnings report is scheduled for 11 Feb 2027. Companies can move their dates.

Around its last 8 reports: what the options market priced, and what followed

Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across SBRA's last 8 reports, ignoring direction, was 2.8%.

0%5%no quote4.0%20 Feb '25no quote0.6%4 Aug '25no quote4.8%5 Nov '25no quote2.9%12 Feb '26no quote0.7%29 Apr '26no quote2.4%3 Aug '26no quote3.1%2 Nov '26no quote2.7%4 Nov '26priced before the reportthe move that followed
What the options market priced for each report, against the size of the move that followed. Priced: the move implied by options expiring after the report, on the last quote before it. Followed: the close before the report to the close after. Sizes only, no direction.

How does SBRA compare with similar companies?

The companies in healthcare facility reits closest to Sabra Health Care REIT in market value, each on the same model and the same date.

CompanyLast closeModel fair valueGapModel verdict
HR Healthcare Realty Trust Incorporated$19.32$17.48-9.5%Overvalued
CTRE CareTrust REIT, Inc.$37.39$33.28-11.0%Overvalued
LTC LTC Properties, Inc.$42.71$56.30+31.8%Undervalued
AHR American Healthcare REIT, Inc.$58.07$22.90-60.6%Gap wider than 60%
DOC Healthpeak Properties, Inc.$19.84$31.13+56.9%Undervalued
OHI Omega Healthcare Investors, Inc.$47.08$51.39+9.2%Undervalued
MPT Medical Properties Trust, Inc.$1.50$5.43+262.0%Gap wider than 60%
VTR Ventas, Inc.$88.90$46.80-47.4%Overvalued

All healthcare facility reit stocks ranked by gap to fair value

Sabra Health Care REIT at a glance

Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Market value
$5.4B
Sector
Real Estate
Industry
Healthcare Facility REITs
Beta to the US market
-0.19
First valued by Faircurve
11 Jul 2026

At the close of 16 Nov 2026, 56.8% of the 1,085 graded US stocks the model covers traded below the model's fair value. SBRA was among them.

How the fair value is worked out: the model values Sabra Health Care REIT three ways and blends them; the range around the fair value comes from 2,000 simulations of the dividend model. The full method is documented here.

What changed in the latest valuation?

On 7 Nov 2026 the model's fair value for SBRA was $17.16. As of 14 Nov 2026 it is $20.72, a change of +20.7%. The model does not yet explain moves on this valuation method. The model revalues every stock it covers each week, and again after an earnings report.

Questions about Sabra Health Care REIT's valuation

Is Sabra Health Care REIT stock undervalued or overvalued?

On Faircurve's model, SBRA reads as Fairly valued as of 14 Nov 2026. The model's fair value is $20.72 a share against a last close of $20.35, a gap of +1.8%.

What is SBRA's fair value?

$20.72 a share as of 14 Nov 2026. The fair value blends three methods: a cash-flow multiple against comparable companies, a dividend model, and the value of the properties. The model's own range is $19.21 to $22.35.

What price range does the model give SBRA?

$16.57 to $24.62 over 63 trading days. Ranges built this way held the price 60% of the time across 13,250 past valuations, refreshed 14 Nov 2026.

When does Sabra Health Care REIT report earnings next?

The next report is scheduled for 11 Feb 2027. Companies can move their dates.

How much has SBRA moved on past earnings reports?

Across its last 8 reports the median two session move was 2.8%, ignoring direction. The largest was +4.8% around the report of 5 Nov 2025.

How confident is the model in this valuation?

The model's evidence grade for SBRA is high. For real estate investment trusts (REITs) the grade looks at the dividend record: at least three years of paid dividends with no cut. It is not a probability that the fair value is right, or that the price reaches it.

The model's own ideas on SBRA

The model holds no idea open on SBRA today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on SBRA with their outcomes. A free account is enough.

Keep reading